Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

NCT06215976 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06215976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06215976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2023
Completion date
December 30, 2024
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle-invasive bladder carcinoma